Liver Steatosis
20
1
1
7
Key Insights
Highlights
Success Rate
88% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.0%
1 terminated out of 20 trials
87.5%
+0.9% vs benchmark
0%
0 trials in Phase 3/4
14%
1 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 7 completed trials
Clinical Trials (20)
Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver Steatosis
STANDARDIZATION OF THE PROTOCOL FOR ATTENUATION COEFFICIENT MEASUREMENT
Interventional AI-Human Collaboration for Steatotic Liver Disease Screening
Impact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Effects of Amino Acid Supplementation on Liver Lipid Content and Protein Metabolism in Obese Children
Endoscopic Ultrasound Shear Wave for Liver Fibrosis in MASLD Patients: The RUMIPAMBA Trial
Acceptability and Feasibility of a New Approach to Engage Patients With Steatotic Liver Disease in Physical Activity
Bariatric Endoscopy and NAFLD
Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)
The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients
"LiverColor": Machine Learning in Liver Photographs
The Sonic Incytes Liver Incyte System, Assessment of Liver Fibrosis and Steatosis
Bariatric Endoscopy and NAFLD
NAFLD and Liver Fibrosis in Obese Adolescents
Controlled Attenuation Parameter (CAP) in Liver Allografts
EXplanted LIver and Ex-vivo Pancreatic Specimen Evaluation by 7 TESLA MRI
China Action on Spine and Hip Status
Clinical Application of Non-invasive Assessment for Staging Liver Steatosis and Liver Fibrosis
Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic Steatosis
Effect of Nigella Sativa on Nonalcoholic Steatohepatitis and Steatosis